Prenatal Testosterone Exposure Disrupts Insulin Secretion And Promotes Insulin Resistance

Hyperandrogenemia and metabolic disturbances during postnatal life are strongly linked both to polycystic ovary syndrome and other conditions that arise from prenatal exposure to androgen excess. In an animal model of this condition, we reported that insulin sensitivity (IS) was lower in young femal...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Scientific reports 2020-01, Vol.10 (1), p.404, Article 404
Hauptverfasser: Carrasco, Albert, Recabarren, Mónica P., Rojas-García, Pedro P., Gutiérrez, Mario, Morales, Karina, Sir-Petermann, Teresa, Recabarren, Sergio E.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 1
container_start_page 404
container_title Scientific reports
container_volume 10
creator Carrasco, Albert
Recabarren, Mónica P.
Rojas-García, Pedro P.
Gutiérrez, Mario
Morales, Karina
Sir-Petermann, Teresa
Recabarren, Sergio E.
description Hyperandrogenemia and metabolic disturbances during postnatal life are strongly linked both to polycystic ovary syndrome and other conditions that arise from prenatal exposure to androgen excess. In an animal model of this condition, we reported that insulin sensitivity (IS) was lower in young female sheep born to testosterone-treated mothers versus sheep born to non-exposed mothers (control). This lower insulin sensitivity remains throughout reproductive life. However, it is unknown whether abnormal postnatal levels of testosterone (T) further decrease IS derived from prenatal exposure to testosterone. Therefore, we assessed the effects of an acute testosterone administration (40 mg) on IS and insulin secretion during an intravenous glucose tolerance test performed at 40 weeks of age (adulthood) in previously ovariectomized sheep at 26 weeks of age (prepuberty), that were either prenatally exposed to testosterone (T-females, n = 6) or not (C-females, n = 6). The incremental area under the curve of insulin was greater in C-females both with or without the acute testosterone treatment (P 
doi_str_mv 10.1038/s41598-019-57197-x
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6962362</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2343282430</sourcerecordid><originalsourceid>FETCH-LOGICAL-c474t-360e71402ee522ae7bf17fdd949338488ebe57878b433e74a296874735bcf90a3</originalsourceid><addsrcrecordid>eNp9kc1KAzEUhYMoKrUv4EIGXI_mb5pkI4hWLRQUfzZuQmZ6R0fapCYZqW_js_hkprbWujEEcuGce-4lH0L7BB8RzORx4KRQMsdE5YUgSuSzDbRLMS9yyijdXKt3UDeEF5xOQRUnahvtMDIvCrWLHm88WBPNOLuHEF2I4J2FrD-butB6yM6b4NtpDNnAhnbc2OwOKg-xcTY7taPPjxvvJi7Cr34LoQnR2Ar20FZtxgG6y7eDHi7692dX-fD6cnB2OswrLnjMWQ-DIBxTgIJSA6KsiahHI8UVY5JLCSUUQgpZcsZAcENVTwouWFFWtcKGddDJInfalhMYVWCjN2M99c3E-HftTKP_KrZ51k_uTfdUj7J0O-hwGeDda5u-Qb-41tu0s6aMMyopZzi56MJVeReCh3o1gWA9R6IXSHRCor-R6FlqOljfbdXyAyAZ2MIQkmSfwP_O_if2C0Mbmi8</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2343282430</pqid></control><display><type>article</type><title>Prenatal Testosterone Exposure Disrupts Insulin Secretion And Promotes Insulin Resistance</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Springer Nature OA Free Journals</source><source>Nature Free</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><creator>Carrasco, Albert ; Recabarren, Mónica P. ; Rojas-García, Pedro P. ; Gutiérrez, Mario ; Morales, Karina ; Sir-Petermann, Teresa ; Recabarren, Sergio E.</creator><creatorcontrib>Carrasco, Albert ; Recabarren, Mónica P. ; Rojas-García, Pedro P. ; Gutiérrez, Mario ; Morales, Karina ; Sir-Petermann, Teresa ; Recabarren, Sergio E.</creatorcontrib><description>Hyperandrogenemia and metabolic disturbances during postnatal life are strongly linked both to polycystic ovary syndrome and other conditions that arise from prenatal exposure to androgen excess. In an animal model of this condition, we reported that insulin sensitivity (IS) was lower in young female sheep born to testosterone-treated mothers versus sheep born to non-exposed mothers (control). This lower insulin sensitivity remains throughout reproductive life. However, it is unknown whether abnormal postnatal levels of testosterone (T) further decrease IS derived from prenatal exposure to testosterone. Therefore, we assessed the effects of an acute testosterone administration (40 mg) on IS and insulin secretion during an intravenous glucose tolerance test performed at 40 weeks of age (adulthood) in previously ovariectomized sheep at 26 weeks of age (prepuberty), that were either prenatally exposed to testosterone (T-females, n = 6) or not (C-females, n = 6). The incremental area under the curve of insulin was greater in C-females both with or without the acute testosterone treatment (P &lt; 0.05). The ISI-Composite was lower after an acute testosterone treatment, only in T-females. We conclude that prenatal exposure to testosterone disrupts pancreatic insulin secretion in response to glucose and that in this setting further hyperandrogenemia may predispose to lower insulin sensitivity.</description><identifier>ISSN: 2045-2322</identifier><identifier>EISSN: 2045-2322</identifier><identifier>DOI: 10.1038/s41598-019-57197-x</identifier><identifier>PMID: 31941959</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>692/163/2743/137/773 ; 692/699/2743/137/773 ; Animal models ; Animals ; Embryonic Development - drug effects ; Female ; Females ; Glucose ; Glucose tolerance ; Humanities and Social Sciences ; Insulin ; Insulin Resistance ; Insulin secretion ; Insulin Secretion - drug effects ; Intravenous administration ; multidisciplinary ; Ovariectomy ; Pancreas ; Polycystic ovary syndrome ; Pregnancy ; Prenatal experience ; Prenatal exposure ; Prenatal Exposure Delayed Effects - chemically induced ; Prenatal Exposure Delayed Effects - metabolism ; Prenatal Exposure Delayed Effects - pathology ; Science ; Science (multidisciplinary) ; Secretion ; Sheep ; Testosterone ; Testosterone - adverse effects</subject><ispartof>Scientific reports, 2020-01, Vol.10 (1), p.404, Article 404</ispartof><rights>The Author(s) 2020</rights><rights>This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c474t-360e71402ee522ae7bf17fdd949338488ebe57878b433e74a296874735bcf90a3</citedby><cites>FETCH-LOGICAL-c474t-360e71402ee522ae7bf17fdd949338488ebe57878b433e74a296874735bcf90a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6962362/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6962362/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,27924,27925,41120,42189,51576,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31941959$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Carrasco, Albert</creatorcontrib><creatorcontrib>Recabarren, Mónica P.</creatorcontrib><creatorcontrib>Rojas-García, Pedro P.</creatorcontrib><creatorcontrib>Gutiérrez, Mario</creatorcontrib><creatorcontrib>Morales, Karina</creatorcontrib><creatorcontrib>Sir-Petermann, Teresa</creatorcontrib><creatorcontrib>Recabarren, Sergio E.</creatorcontrib><title>Prenatal Testosterone Exposure Disrupts Insulin Secretion And Promotes Insulin Resistance</title><title>Scientific reports</title><addtitle>Sci Rep</addtitle><addtitle>Sci Rep</addtitle><description>Hyperandrogenemia and metabolic disturbances during postnatal life are strongly linked both to polycystic ovary syndrome and other conditions that arise from prenatal exposure to androgen excess. In an animal model of this condition, we reported that insulin sensitivity (IS) was lower in young female sheep born to testosterone-treated mothers versus sheep born to non-exposed mothers (control). This lower insulin sensitivity remains throughout reproductive life. However, it is unknown whether abnormal postnatal levels of testosterone (T) further decrease IS derived from prenatal exposure to testosterone. Therefore, we assessed the effects of an acute testosterone administration (40 mg) on IS and insulin secretion during an intravenous glucose tolerance test performed at 40 weeks of age (adulthood) in previously ovariectomized sheep at 26 weeks of age (prepuberty), that were either prenatally exposed to testosterone (T-females, n = 6) or not (C-females, n = 6). The incremental area under the curve of insulin was greater in C-females both with or without the acute testosterone treatment (P &lt; 0.05). The ISI-Composite was lower after an acute testosterone treatment, only in T-females. We conclude that prenatal exposure to testosterone disrupts pancreatic insulin secretion in response to glucose and that in this setting further hyperandrogenemia may predispose to lower insulin sensitivity.</description><subject>692/163/2743/137/773</subject><subject>692/699/2743/137/773</subject><subject>Animal models</subject><subject>Animals</subject><subject>Embryonic Development - drug effects</subject><subject>Female</subject><subject>Females</subject><subject>Glucose</subject><subject>Glucose tolerance</subject><subject>Humanities and Social Sciences</subject><subject>Insulin</subject><subject>Insulin Resistance</subject><subject>Insulin secretion</subject><subject>Insulin Secretion - drug effects</subject><subject>Intravenous administration</subject><subject>multidisciplinary</subject><subject>Ovariectomy</subject><subject>Pancreas</subject><subject>Polycystic ovary syndrome</subject><subject>Pregnancy</subject><subject>Prenatal experience</subject><subject>Prenatal exposure</subject><subject>Prenatal Exposure Delayed Effects - chemically induced</subject><subject>Prenatal Exposure Delayed Effects - metabolism</subject><subject>Prenatal Exposure Delayed Effects - pathology</subject><subject>Science</subject><subject>Science (multidisciplinary)</subject><subject>Secretion</subject><subject>Sheep</subject><subject>Testosterone</subject><subject>Testosterone - adverse effects</subject><issn>2045-2322</issn><issn>2045-2322</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp9kc1KAzEUhYMoKrUv4EIGXI_mb5pkI4hWLRQUfzZuQmZ6R0fapCYZqW_js_hkprbWujEEcuGce-4lH0L7BB8RzORx4KRQMsdE5YUgSuSzDbRLMS9yyijdXKt3UDeEF5xOQRUnahvtMDIvCrWLHm88WBPNOLuHEF2I4J2FrD-butB6yM6b4NtpDNnAhnbc2OwOKg-xcTY7taPPjxvvJi7Cr34LoQnR2Ar20FZtxgG6y7eDHi7692dX-fD6cnB2OswrLnjMWQ-DIBxTgIJSA6KsiahHI8UVY5JLCSUUQgpZcsZAcENVTwouWFFWtcKGddDJInfalhMYVWCjN2M99c3E-HftTKP_KrZ51k_uTfdUj7J0O-hwGeDda5u-Qb-41tu0s6aMMyopZzi56MJVeReCh3o1gWA9R6IXSHRCor-R6FlqOljfbdXyAyAZ2MIQkmSfwP_O_if2C0Mbmi8</recordid><startdate>20200115</startdate><enddate>20200115</enddate><creator>Carrasco, Albert</creator><creator>Recabarren, Mónica P.</creator><creator>Rojas-García, Pedro P.</creator><creator>Gutiérrez, Mario</creator><creator>Morales, Karina</creator><creator>Sir-Petermann, Teresa</creator><creator>Recabarren, Sergio E.</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>5PM</scope></search><sort><creationdate>20200115</creationdate><title>Prenatal Testosterone Exposure Disrupts Insulin Secretion And Promotes Insulin Resistance</title><author>Carrasco, Albert ; Recabarren, Mónica P. ; Rojas-García, Pedro P. ; Gutiérrez, Mario ; Morales, Karina ; Sir-Petermann, Teresa ; Recabarren, Sergio E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c474t-360e71402ee522ae7bf17fdd949338488ebe57878b433e74a296874735bcf90a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>692/163/2743/137/773</topic><topic>692/699/2743/137/773</topic><topic>Animal models</topic><topic>Animals</topic><topic>Embryonic Development - drug effects</topic><topic>Female</topic><topic>Females</topic><topic>Glucose</topic><topic>Glucose tolerance</topic><topic>Humanities and Social Sciences</topic><topic>Insulin</topic><topic>Insulin Resistance</topic><topic>Insulin secretion</topic><topic>Insulin Secretion - drug effects</topic><topic>Intravenous administration</topic><topic>multidisciplinary</topic><topic>Ovariectomy</topic><topic>Pancreas</topic><topic>Polycystic ovary syndrome</topic><topic>Pregnancy</topic><topic>Prenatal experience</topic><topic>Prenatal exposure</topic><topic>Prenatal Exposure Delayed Effects - chemically induced</topic><topic>Prenatal Exposure Delayed Effects - metabolism</topic><topic>Prenatal Exposure Delayed Effects - pathology</topic><topic>Science</topic><topic>Science (multidisciplinary)</topic><topic>Secretion</topic><topic>Sheep</topic><topic>Testosterone</topic><topic>Testosterone - adverse effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Carrasco, Albert</creatorcontrib><creatorcontrib>Recabarren, Mónica P.</creatorcontrib><creatorcontrib>Rojas-García, Pedro P.</creatorcontrib><creatorcontrib>Gutiérrez, Mario</creatorcontrib><creatorcontrib>Morales, Karina</creatorcontrib><creatorcontrib>Sir-Petermann, Teresa</creatorcontrib><creatorcontrib>Recabarren, Sergio E.</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Scientific reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Carrasco, Albert</au><au>Recabarren, Mónica P.</au><au>Rojas-García, Pedro P.</au><au>Gutiérrez, Mario</au><au>Morales, Karina</au><au>Sir-Petermann, Teresa</au><au>Recabarren, Sergio E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prenatal Testosterone Exposure Disrupts Insulin Secretion And Promotes Insulin Resistance</atitle><jtitle>Scientific reports</jtitle><stitle>Sci Rep</stitle><addtitle>Sci Rep</addtitle><date>2020-01-15</date><risdate>2020</risdate><volume>10</volume><issue>1</issue><spage>404</spage><pages>404-</pages><artnum>404</artnum><issn>2045-2322</issn><eissn>2045-2322</eissn><abstract>Hyperandrogenemia and metabolic disturbances during postnatal life are strongly linked both to polycystic ovary syndrome and other conditions that arise from prenatal exposure to androgen excess. In an animal model of this condition, we reported that insulin sensitivity (IS) was lower in young female sheep born to testosterone-treated mothers versus sheep born to non-exposed mothers (control). This lower insulin sensitivity remains throughout reproductive life. However, it is unknown whether abnormal postnatal levels of testosterone (T) further decrease IS derived from prenatal exposure to testosterone. Therefore, we assessed the effects of an acute testosterone administration (40 mg) on IS and insulin secretion during an intravenous glucose tolerance test performed at 40 weeks of age (adulthood) in previously ovariectomized sheep at 26 weeks of age (prepuberty), that were either prenatally exposed to testosterone (T-females, n = 6) or not (C-females, n = 6). The incremental area under the curve of insulin was greater in C-females both with or without the acute testosterone treatment (P &lt; 0.05). The ISI-Composite was lower after an acute testosterone treatment, only in T-females. We conclude that prenatal exposure to testosterone disrupts pancreatic insulin secretion in response to glucose and that in this setting further hyperandrogenemia may predispose to lower insulin sensitivity.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>31941959</pmid><doi>10.1038/s41598-019-57197-x</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2045-2322
ispartof Scientific reports, 2020-01, Vol.10 (1), p.404, Article 404
issn 2045-2322
2045-2322
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6962362
source MEDLINE; DOAJ Directory of Open Access Journals; Springer Nature OA Free Journals; Nature Free; EZB-FREE-00999 freely available EZB journals; PubMed Central; Free Full-Text Journals in Chemistry
subjects 692/163/2743/137/773
692/699/2743/137/773
Animal models
Animals
Embryonic Development - drug effects
Female
Females
Glucose
Glucose tolerance
Humanities and Social Sciences
Insulin
Insulin Resistance
Insulin secretion
Insulin Secretion - drug effects
Intravenous administration
multidisciplinary
Ovariectomy
Pancreas
Polycystic ovary syndrome
Pregnancy
Prenatal experience
Prenatal exposure
Prenatal Exposure Delayed Effects - chemically induced
Prenatal Exposure Delayed Effects - metabolism
Prenatal Exposure Delayed Effects - pathology
Science
Science (multidisciplinary)
Secretion
Sheep
Testosterone
Testosterone - adverse effects
title Prenatal Testosterone Exposure Disrupts Insulin Secretion And Promotes Insulin Resistance
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T08%3A46%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prenatal%20Testosterone%20Exposure%20Disrupts%20Insulin%20Secretion%20And%C2%A0Promotes%20Insulin%20Resistance&rft.jtitle=Scientific%20reports&rft.au=Carrasco,%20Albert&rft.date=2020-01-15&rft.volume=10&rft.issue=1&rft.spage=404&rft.pages=404-&rft.artnum=404&rft.issn=2045-2322&rft.eissn=2045-2322&rft_id=info:doi/10.1038/s41598-019-57197-x&rft_dat=%3Cproquest_pubme%3E2343282430%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2343282430&rft_id=info:pmid/31941959&rfr_iscdi=true